August 06, 2010 | Injection Treatments
Xeomin Injectable Wrinkle Relaxer Reaches U.S.: What You Need to Know
Xeomin, a botulinum type A injectable treatment made by German pharmaceutical giant Merz, was finally FDA-approved to join Botox and Dysport on the U.S. market in late September, after having been available in Europe since 2008. Xeomin will likely compete with Botox and Dysport for a share of patients seeking to reduce forehead creases and […]
Read More